Andreoni K A, Brayman K L, Guidinger M K, Sommers C M, Sung R S
Surgery, University of North Carolina Hospitals, Chapel Hill, North Carolina, USA.
Am J Transplant. 2007;7(5 Pt 2):1359-75. doi: 10.1111/j.1600-6143.2006.01781.x.
Kidney and pancreas transplantation in 2005 improved in quantity and outcome quality, despite the increasing average age of kidney graft recipients, with 56% aged 50 or older. Geography and ABO blood type contribute to the discrepancy in waiting time among the deceased donor (DD) candidates. Allocation policy changes are decreasing the median times to transplant for pediatric recipients. Overall, 6% more DD kidney transplants were performed in 2005 with slight increases in standard criteria donors (SCD) and expanded criteria donors (ECD). The largest increase (39%) was in donation after cardiac death (DCD) from non-ECD donors. These DCD, non-ECD kidneys had equivalent outcomes to SCD kidneys. 1-, 3- and 5-year unadjusted graft survival was 91%, 80% and 70% for non-ECD-DD transplants, 82%, 68% and 53% for ECD-DD grafts, and 95%, 88% and 80% for living donor kidney transplants. In 2005, 27% of patients were discharged without steroids compared to 3% in 1999. Acute rejection decreased to 11% in 2004. There was a slight increase in the number of simultaneous pancreas-kidney transplants (895), with fewer pancreas after kidney transplants (343 from 419 in 2004), and a stable number of pancreas alone transplants (129). Pancreas underutilization appears to be an ongoing issue.
2005年,肾脏和胰腺移植在数量和结果质量方面均有所改善,尽管肾移植受者的平均年龄不断增加,其中56%的受者年龄在50岁及以上。地理位置和ABO血型导致了已故供体(DD)候选者等待时间的差异。分配政策的变化正在缩短儿科受者的移植中位时间。总体而言,2005年进行的DD肾移植增加了6%,标准标准供体(SCD)和扩展标准供体(ECD)略有增加。增幅最大的(39%)是来自非ECD供体的心脏死亡后捐赠(DCD)。这些DCD、非ECD肾脏的结果与SCD肾脏相当。非ECD-DD移植的1年、3年和5年未调整移植存活率分别为91%、80%和70%,ECD-DD移植为82%、68%和53%,活体供肾移植为95%、88%和80%。2005年,27%的患者出院时未使用类固醇,而1999年为3%。2004年急性排斥反应降至11%。同期胰腺-肾脏联合移植数量略有增加(895例),肾后胰腺移植数量减少(从2004年的419例降至343例),单独胰腺移植数量稳定(129例)。胰腺利用不足似乎仍然是一个问题。